Previous 10 | Next 10 |
Betsy Nabel and Jeff Brodsky join Accolade Board of Directors New board directors bring expertise in healthcare services, policy, and human resources PR Newswire SEATTLE , June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcar...
This technology-focused healthcare infrastructure platform connects payors, providers, and employers in an efficient and analytical way. As a new growth-based company seeing 40% CAGR revenues over the past two years, net income remains negative but profitability is higher than their p...
Gainers: [[VRNA]] +31.8%. [[PDD]] +6.1%. [[SHYF]] +4.6%. [[OCX]] +3.9%. [[VERI]] +3.9%.Losers: [[IOVA]] -11.1%. [[PRPL]] -4.0%. [[PRVB]] -3.4%. [[OZON]] -3.3%. [[ACCD]] -3.0%. For further details see: VRNA, PDD, IOVA and PRVB among after-hours movers
Accolade, Inc. (ACCD) Q4 2021 Results Conference Call May 05, 2021 04:30 PM ET Company Participants Todd Friedman - Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nundy - Chief Medical Officer Conference Call Participants Michael Cher...
The following slide deck was published by Accolade, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Accolade, Inc. 2021 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Accolade, Inc. (NASDAQ: ACCD) Q4 2021 Earnings Call May 05, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Accolade, Inc. (ACCD) Q4 2021 Earnings Call Transcript
Fiscal fourth quarter 2021 revenue of $59.2 million, a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million Fiscal year 2021 revenue of $170.4 million, a 29% increase compared to fiscal year 2020 revenue of $132.5 million Initiates guidance for...
Accolade (ACCD): Q4 GAAP EPS of -$1.72 misses by $1.62.Revenue of $59.2M beats by $2.72M.Initiates guidance for fiscal year 2022 revenue in the range of $260M to $265M, with Adjusted EBITDA in the range of $(38)M to $(42)MPress Release For further details see: Accolade EPS misses by $1....
Fiscal fourth quarter 2021 revenue of $59.2 million, a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million Fiscal year 2021 revenue of $170.4 million, a 29% increase compared to fiscal year 2020 revenue of $132.5 million Initiates guidance for...
Accolade (ACCD) agrees to acquire, a leading provider of virtual primary care and mental health consultant PlushCare.The deal value of ~$450M, consists of ~$40M in cash and $340M in common stock and an additional $70M of value payable upon the achievement of defined revenue mileston...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...